Publications

Suppression of endothelial ceramide de novo biosynthesis by Nogo-B contributes to cardiometabolic diseases

 79
Suppression of endothelial ceramide de novo biosynthesis by Nogo-B contributes to cardiometabolic diseases

Tags:

Previous Article

ALS drug effectively treats Alzheimer’s disease

Next Article

Inhibition of ceramide synthesis contributes to cardiometabolic diseases

Related Posts

Deciphering the MYCN-driven metabolic microenvironment of neuroblastoma

Deciphering the MYCN-driven metabolic microenvironment ...

 48

Mislocalization of nucleic acids is a convergent and targetable mechanism in Alzheimer’s disease and frontotemporal dementia

Mislocalization of nucleic acids is a convergent and ta...

 78

Brain tumors induce widespread disruption of calvarial bone and alteration of skull marrow immune landscape

Brain tumors induce widespread disruption of calvarial ...

 18